Predominant autoantibody production by early human B cell precursors

Science

Volumn 301, Issue 5638, 2003, Pages 1374-1377

  Wardemann, Hedda ^a   Yurasov, Sergey ^a,b   Schaefer, Anne ^a   Young, James W ^b   Meffre, Eric ^a,c   Nussenzweig, Michel C ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; GENES;

SELF REACTIVITY;

IMMUNOLOGY;

AUTOANTIBODY;

ANTIBODY; GENE;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL MATURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PREVALENCE; PRIORITY JOURNAL; STEM CELL;

ANTIBODIES, ANTINUCLEAR; ANTIBODY DIVERSITY; ANTIBODY SPECIFICITY; AUTOANTIBODIES; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; COMPLEMENTARITY DETERMINING REGIONS; CYTOSOL; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; RECOMBINATION, GENETIC; SELECTION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0041689676     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1086907     Document Type: Article

References (36)

1. A. M. Silverstein, Nature Immunol. 2, 279 (2001).
2. K. Landsteiner, The Specificity of Serological Reactions (Dover, New York, 1936).
3. D. Gay, T. Saunders, S. Camper, M. Weigert, J. Exp. Med. 177, 999 (1993).
4. S. L. Tiegs, D. M. Russell, D. Nemazee, J. Exp. Med. 177, 1009 (1993).
5. D. A. Nemazee, K. Burki, Nature 337, 562 (1989).
6. C. C. Goodnow et al., Nature 334, 676 (1988).
7. See supporting data on Science Online.
8. L. G. Billips et al., Ann. N.Y. Acad. Sci. 764, 1 (1995).
9. K. D. Klonowski, L. L. Primiano, M. Monestier, J. Immunol. 162, 1566 (1999).
10. Y. Ichiyoshi, P. Casali, J. Exp. Med. 180, 885 (1994).
11. R. Crouzier, T. Martin, J. L. Pasquali, J. Immunol. 154, 4526 (1995).
12. I. Aguilera, J. Melero, A. Nunez-Roldan, B. Sanchez, Immunology 102, 273 (2001).
13. S. Shiokawa et al., J. Immunol. 162, 6060 (1999).
14. E. Meffre et al., J. Clin. Invest. 108, 879 (2001).
15. M. Z. Radic, M. Weigert, Annu. Rev. Immunol. 12, 487 (1994).
16. S. M. Barbas et al., Proc. Natl. Acad. Sci. U.S.A. 92, 2529 (1995).
17. J. M. Seigneurin, B. Guilbert, M. J. Bourgeat, S. Avrameas, Blood 71, 581 (1988).
18. V. Guigou et al., J. Immunol. 146, 1368 (1991).
19. D. Leslie, P. Lipsky, A. L. Notkins, J. Clin. Invest. 108, 1417 (2001).
20. K. Rajewsky, Nature 381, 751 (1996).
21. A. Rolink et al., J. Exp. Med. 178, 1263 (1993).
22. W. Yu et al., Nature 400, 682 (1999).
23. R. J. Monroe et al., Immunity 11, 201 (1999).
24. R. Kleinfield et al., Nature 322, 843 (1986).
25. M. Reth, P. Gehrmann, E. Petrac, P. Wiese, Nature 322, 840 (1986).
26. M. W. Retter, D. Nemazee, J. Exp. Med. 188, 1231 (1998).
27. R. Casellas et al., Science 291, 1541 (2001).
28. D. Nemazee, M. Weigert, J. Exp. Med. 191, 1813 (2000).
29. L. B. King, J. G. Monroe, Immunol. Rev. 176, 86 (2000).
30. D. M. Allman, S. E. Ferguson, V. M. Lentz, M. P. Cancro, J. Immunol. 151, 4431 (1993).
31. A. G. Rolink, J. Andersson, F. Melchers, Eur. J. Immunol. 28, 3738 (1998).
32. H. Gu et al., J. Exp. Med. 173, 1357 (1991).
33. N. Baumgarth et al., J. Exp. Med. 192, 271 (2000).
34. A. F. Ochsenbein et al., Science 286, 2156 (1999).
35. F. Martin, J. F. Kearney, Immunol. Rev. 175, 70 (2000).
36. We thank K. Velinzon and K. Gordon for help with the single cell sorter, and all members of the Nussenzweig laboratory and E. Besmer for help with the manuscript. Supported by grants from NIH and the Leukemia-Lymphoma Society (M.C.N. and J.W.Y.) and from the Dana Foundation (E.M.). M.C.N. is a Howard Hughes Medical Institute investigator.